ALFA’s top 10 holdings, a group that combines for about 30% of the ETF’s weight, include Apple (NasdaqGS: AAPL), Valeant Pharmaceuticals (NYSE: VRX), Oracle (NYSE: ORCL), Pricelien (NasdaqGS: PCLN) and Celgene (NasdaqGS: CELG).
The ETF charges 0.95% per year and had over $162 million in assets under management as of June 17.
AlphaClone Alternative Alpha ETF
ETF Trends editorial team contributed to this post. Tom Lydon’s clients own shares of Apple.